Final report of post-marketing survey of panitumumab in Japanese patients with unresectable advanced or recurrent colorectal cancer.
Tetsuya Hamaguchi
Consultant or Advisory Role - Nippon Kayaku; Takeda
Honoraria - Astellas Pharma; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Yakult
Narikazu Boku
Consultant or Advisory Role - Takeda
Kenichi Sugihara
Consultant or Advisory Role - Chugai Pharma; Taiho Pharmaceutical; Takeda
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Merck Serono; Otsuka; Taiho Pharmaceutical; Takeda; Yakult
Yuko Kitagawa
Consultant or Advisory Role - Takeda
Honoraria - Takeda
Hiroya Takiuchi
Consultant or Advisory Role - Takeda
Kiyohiko Hatake
Consultant or Advisory Role - Takeda
Kei Muro
Consultant or Advisory Role - Takeda
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult
Takayuki Yoshino
Consultant or Advisory Role - Takeda
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Takeda; Yakult
Research Funding - Bayer; Daiichi Sankyo; ImClone Systems; Taiho Pharmaceutical
Naoya Yamazaki
Consultant or Advisory Role - Bristol-Myers Squibb; Merck Serono; Takeda
Honoraria - Bristol-Myers Squibb; Merck Serono; Takeda
Akihiko Gemma
Consultant or Advisory Role - Takeda
Ikuo Yana
Employment or Leadership Position - Takeda
Hiroshi Ueno
Employment or Leadership Position - Takeda
Atsushi Ohtsu
Consultant or Advisory Role - Chugai Pharma; Daiichi Sankyo; Novartis; Taiho Pharmaceutical; Takeda
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Merck Serono; Pfizer; Taiho Pharmaceutical; Takeda; Yakult